glp-1 pharmacology glp-1_analogs [TUSOM GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
A day after Eli Lilly gained FDA approval for its obesity pill Foundayo, Novo Nordisk is fighting back with an analysis that it says shows the superiority of its own oral drug.
As consumers continue to take their health and wellness goals seriously, GLP-1 drug usage will continue to grow.
Ozempic mouth is a common phrase for mouth changes that some people notice on GLP-1 meds like Ozempic or Wegovy
Objective The aim was to compare the risk of incident AF after initiation of GLP-1RAs versus dipeptidyl peptidase-4 inhibitors (DPP4is), as active comparators, in patients with DM
Those with obesity might have other serious chronic health conditions, including diabetes and high blood pressure, which are leading risk factors for heart disease and stroke
Anderson: A Pioneer Dedicated to Solving Obesity Issues
